Chang AE - Search Results

1

Rate of freeze alters the immunologic response after cryoablation of breast cancer.

Sabel MS, Su G, Griffith KA, Chang AE. Sabel MS, et al. Among authors: chang ae. Ann Surg Oncol. 2010 Apr;17(4):1187-93. doi: 10.1245/s10434-009-0846-1. Epub 2009 Dec 22. Ann Surg Oncol. 2010. PMID: 20033323

2

A novel role for autologous tumour cell vaccination in the immunotherapy of the poorly immunogenic B16-BL6 melanoma.

Geiger JD, Wagner PD, Shu S, Chang AE. Geiger JD, et al. Among authors: chang ae. Surg Oncol. 1992 Jun;1(3):199-208. doi: 10.1016/0960-7404(92)90065-s. Surg Oncol. 1992. PMID: 1341252 Free article.

3

Immunotherapy with sensitized lymphocytes.

Chang AE, Shu S. Chang AE, et al. Cancer Invest. 1992;10(5):357-69. doi: 10.3109/07357909209024795. Cancer Invest. 1992. PMID: 1393687 Review. No abstract available.

4

Divergent effects of TNF alpha in the adoptive immunotherapy of a murine sarcoma.

Wagner PD, Shu S, Chang AE. Wagner PD, et al. Among authors: chang ae. J Surg Res. 1992 Aug;53(2):152-7. doi: 10.1016/0022-4804(92)90027-w. J Surg Res. 1992. PMID: 1405603 Free article.

5

Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cells.

Yoshizawa H, Chang AE, Shu SY. Yoshizawa H, et al. Among authors: chang ae. Cancer Res. 1992 Mar 1;52(5):1129-36. Cancer Res. 1992. PMID: 1531321

6

Activation by anti-CD3 of tumor-draining lymph node cells for specific adoptive immunotherapy.

Yoshizawa H, Sakai K, Chang AE, Shu SY. Yoshizawa H, et al. Among authors: chang ae. Cell Immunol. 1991 May;134(2):473-9. doi: 10.1016/0008-8749(91)90318-6. Cell Immunol. 1991. PMID: 1827049 Free article.

7

Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2.

Yoshizawa H, Chang AE, Shu S. Yoshizawa H, et al. Among authors: chang ae. J Immunol. 1991 Jul 15;147(2):729-37. J Immunol. 1991. PMID: 1830072

8

Enhancing effect of interleukin 1 alpha administration on antitumor effector T-cell development.

Sondak VK, Tuck MK, Shu S, Yoshizawa H, Chang AE. Sondak VK, et al. Among authors: chang ae. Arch Surg. 1991 Dec;126(12):1503-8; discussion 1508-9. doi: 10.1001/archsurg.1991.01410360077012. Arch Surg. 1991. PMID: 1842180

9

Enhanced antitumor reactivity of tumor-sensitized T cells by interferon alfa.

Vander Woude DL, Wagner PD, Shu S, Chang AE. Vander Woude DL, et al. Among authors: chang ae. Arch Surg. 1991 Mar;126(3):307-13. doi: 10.1001/archsurg.1991.01410270047009. Arch Surg. 1991. PMID: 1998472

10

Suppressive effects of visceral tumor on the generation of antitumor T cells for adoptive immunotherapy.

Sondak VK, Wagner PD, Shu S, Chang AE. Sondak VK, et al. Among authors: chang ae. Arch Surg. 1991 Apr;126(4):442-6. doi: 10.1001/archsurg.1991.01410280040005. Arch Surg. 1991. PMID: 2009059

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results